The functional significance of tetrandrine-induced MHC-I upregulation was further validated by in vitro and in vivo experiments demonstrating enhanced CD8+ T cell recognition and killing of melanoma cells (Figs. 2, 7). The gene discussed is CD8A; the disease is melanoma.